Literature DB >> 18815816

Diagnostic accuracy of urine dipsticks for detecting albuminuria in indigenous and non-indigenous children in a community setting.

Leigh Haysom1, Rita Williams, Elisabeth Hodson, Pamela Lopez-Vargas, L Paul Roy, David Lyle, Jonathan C Craig.   

Abstract

Albuminuria predicts cardiovascular and end-stage kidney disease in indigenous populations. Early detection in indigenous children may identify those who could benefit from early treatment. Community-based detection of albuminuria needs to be performed using a reliable, inexpensive, and widely available test, such as a proteinuria dipstick. Dipstick accuracy for detecting albuminuria in a community setting has not been evaluated. We assessed the accuracy of Multistix 10 SG dipsticks to detect baseline albuminuria and predict for persistent albuminuria at a 2-year follow-up in a population-based cohort of Australian Aboriginal and non-Aboriginal elementary-school-aged children. Variability in the accuracy of dipsticks in subgroups of higher risk children was analyzed using the relative diagnostic odds ratio (RDOR). Using Multistix 10 SG dipsticks, index-test-positive cases were defined as >/=0.30 g/L (1+) proteinuria and index-test-negative cases as <0.30 g/L (negative or trace) proteinuria. Referent-test-positive cases were defined as spot albumin:creatinine (ACR) >/=3.4 mg/mmol, and referent-test-negative cases as ACR <3.4 mg/mmol. There were 2,266 children (55.1% Aboriginal, 51.0% boys, mean age 8.9 years) enrolled. At the 2-year follow-up, 1,432 (63.0%) children were retested (54.0% Aboriginal, 50.5% boys, mean age 10.5 years). Prevalence of baseline albuminuria was 7.3%, and persistent albuminuria was 1.5%. Dipsticks had a sensitivity of 62% and specificity of 97% at baseline. In predicting persistent albuminuria, sensitivity was 75% and specificity 93%. Accuracy did not vary with ethnicity, gender, or body mass index. Accuracy was less in younger children (4.0-7.9 years), and in those with hematuria. The performance characteristics of Multistix dipsticks make them suitable for albuminuria detection in Aboriginal and other higher-risk groups of children. More than two thirds of children detected at a single test will have transient rather than persistent albuminuria. Multistix dipsticks are particularly useful for detecting children who will have persistent albuminuria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815816     DOI: 10.1007/s00467-008-0988-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  The diagnostic odds ratio: a single indicator of test performance.

Authors:  Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick M M Bossuyt
Journal:  J Clin Epidemiol       Date:  2003-11       Impact factor: 6.437

3.  Racial misclassification and disparities in cardiovascular disease among American Indians and Alaska Natives.

Authors:  Dorothy A Rhoades
Journal:  Circulation       Date:  2005-03-15       Impact factor: 29.690

Review 4.  Chronic kidney disease in the general population.

Authors:  S L White; A Cass; R C Atkins; S J Chadban
Journal:  Adv Chronic Kidney Dis       Date:  2005-01       Impact factor: 3.620

5.  Dipstick analysis of urinary protein. A comparison of Chemstrip-9 and Multistix-10SG.

Authors:  J K Allen; E A Krauss; R G Deeter
Journal:  Arch Pathol Lab Med       Date:  1991-01       Impact factor: 5.534

6.  Renal disease, the metabolic syndrome, and cardiovascular disease.

Authors:  Wendy E Hoy; Srinivas Kondalsamy-Chennakesavan; Stephen McDonald; Zhiqiang Wang
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

7.  Use of single voided urine samples to estimate quantitative proteinuria.

Authors:  J M Ginsberg; B S Chang; R A Matarese; S Garella
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

8.  Early chronic kidney disease in Aboriginal and non-Aboriginal Australian children: remoteness, socioeconomic disadvantage or race?

Authors:  L Haysom; R Williams; E Hodson; L P Roy; D Lyle; J C Craig
Journal:  Kidney Int       Date:  2007-02-21       Impact factor: 10.612

Review 9.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  BMJ       Date:  2003-01-04

10.  Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand.

Authors:  Stephen P McDonald; Graemer R Russ
Journal:  Nephrology (Carlton)       Date:  2003-02       Impact factor: 2.506

View more
  3 in total

1.  Screening for kidney disease in children on World Kidney Day in Jalisco, Mexico.

Authors:  Susan M Koshy; Guillermo Garcia-Garcia; Jacob Sandoval Pamplona; Karina Renoirte-Lopez; Gustavo Perez-Cortes; Ma Luisa Salazar Gutierrez; Brenda Hemmelgarn; Anita Lloyd; Marcello Tonelli
Journal:  Pediatr Nephrol       Date:  2009-03-07       Impact factor: 3.714

2.  Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents.

Authors:  Siah Kim; Petra Macaskill; Elisabeth M Hodson; Jennifer Daylight; Rita Williams; Rachael Kearns; Nicola Vukasin; David M Lyle; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2016-06-23       Impact factor: 3.714

Review 3.  Non-Traditional Risk Factors of Albuminuria in the Pediatric Population: A Scoping Review.

Authors:  Erick Sierra-Diaz; Alfredo de Jesus Celis-de la Rosa; Felipe Lozano-Kasten; Alejandro Bravo-Cuellar; Mariana Garcia-Gutierrez; Hernandez-Flores Georgina
Journal:  Int J Environ Res Public Health       Date:  2017-10-16       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.